Endocrinology, Vol 137, 166-174, Copyright © 1996 by Endocrine Society

ARTICLES

Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism

N Fournet, SR Weitsman, RJ Zachow and DA Magoffin
Department of Obstetrics and Gynecology, Cedars-Sinai Research Institute/University of California, Los Angeles School of Medicine 90048, USA.

Transforming growth factor-beta1 (TGF-beta1) inhibits theca- interstitial cell (TIC) androgen biosynthesis while enhancing progesterone production without altering P45017 alpha protein content. The purpose of the present study was to define the mechanism of TGF- beta 1 inhibition of ovarian androgen production by determining the effects of TGF-beta 1 on steroidogenic enzyme messenger RNA (mRNA) expression and 17 alpha-hydroxylase activity in TIC in vitro. TIC isolated from hypophysectomized immature rat ovaries by Percoll gradient centrifugation were cultured with and without LH and TGF-beta 1 up to 6 days. At various times, cytoplasmic mRNA was extracted from the TIC, and P450scc, 3 beta-HSD and P450(17 alpha) mRNA were measured by specific assays, using RT-PCR. Treatment with TGF-beta 1 alone (0.1- 100 ng/ml) had no effect on mRNA expression at 2 days but increased P450scc and 3 beta-HDS mRNA at 4 days. TGF-beta did not alter the LH stimulation of P450scc and 3 beta-HSD mRNA up to 6 days but caused a modest (2.5-fold) increase in P450 (17 alpha) mRNA at 2 days. Specificity studies with inhibin-A (30 ng/ml), activin-A (100 ng/ml), and MIS (300 ng/ml) demonstrated that the effects of TGF-beta 1 were unique within this family of peptides. We next examined the effect of TGF-beta 1 on 17 alpha-hydroxylase activity. Kinetic analysis revealed that the 17 alpha-hydroxylase enzyme has an apparent Michaelis-Menten constant of 3.42 mumol/liter and maximum velocity of 0.23 pmol/min x mg protein. TGF-beta 1 inhibited 17 alpha-hydroxylase activity by a noncompetitive mechanism with an apparent inhibin constant (Ki) of 46.4 pM. The results of our studies demonstrate that TGF-beta 1 directly inhibits TIC androgen production by a noncompetitive mechanism. This novel mechanism may be important in preventing excessive androgen production in developing ovarian follicles without preventing differentiation of the TIC.

This article has been cited by other articles:

				G. Irusta, F. Parborell, and M. Tesone Inhibition of cytochrome P-450 C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1456 - E1464. [Abstract] [Full Text] [PDF]

				J. Smitz, A.N. Andersen, P. Devroey, J.-C. Arce, and for the MERIT Group Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients Hum. Reprod., March 1, 2007; 22(3): 676 - 687. [Abstract] [Full Text] [PDF]

				P. G Knight and C. Glister TGF-{beta} superfamily members and ovarian follicle development. Reproduction, August 1, 2006; 132(2): 191 - 206. [Abstract] [Full Text] [PDF]

				J. Greenaway, P. A. Gentry, J.-J. Feige, J. LaMarre, and J. J. Petrik Thrombospondin and Vascular Endothelial Growth Factor Are Cyclically Expressed in an Inverse Pattern During Bovine Ovarian Follicle Development Biol Reprod, May 1, 2005; 72(5): 1071 - 1078. [Abstract] [Full Text] [PDF]

				A. J. Jakimiuk, S. R. Weitsman, H.-W. Yen, M. Bogusiewicz, and D. A. Magoffin Estrogen Receptor {alpha} and {beta} Expression in Theca and Granulosa Cells from Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5532 - 5538. [Abstract] [Full Text] [PDF]

				J. J. Petrik, P. A. Gentry, J.-J. Feige, and J. LaMarre Expression and Localization of Thrombospondin-1 and -2 and Their Cell-Surface Receptor, CD36, During Rat Follicular Development and Formation of the Corpus Luteum Biol Reprod, November 1, 2002; 67(5): 1522 - 1531. [Abstract] [Full Text] [PDF]

				J. R. Schwartz and S. K. Roy Developmental Expression of Cytochrome P450 Side-Chain Cleavage and Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid and Protein in the Neonatal Hamster Ovary Biol Reprod, December 1, 2000; 63(6): 1586 - 1593. [Abstract] [Full Text]

				J. R. Schwartz and S. K. Roy Expression of P450 Side-Chain Cleavage (CYP11A1) and P450 17{alpha}-Hydroxylase-17/20 Lyase (CYP17) Messenger Ribonucleic Acid in Hamster Primary Interstitial Cells In Vitro: Differential Regulation of Steroidogenesis by Cyclic Adenosine Monophosphate Biol Reprod, August 1, 2000; 63(2): 503 - 507. [Abstract] [Full Text]

				J. Qu, P. A. Godin, M. Nisolle, and J. Donnez Expression of receptors for insulin-like growth factor-I and transforming growth factor-{beta} in human follicles Mol. Hum. Reprod., February 1, 2000; 6(2): 137 - 145. [Abstract] [Full Text] [PDF]

				S. K. Roy, S. G. Kurz, A. M. Carlson, C. J. DeJonge, J. W. Ramey, and V. M. Maclin Transforming Growth Factor ß Receptor Expression in Hyperstimulated Human Granulosa Cells and Cleavage Potential of the Zygotes Biol Reprod, December 1, 1998; 59(6): 1311 - 1316. [Abstract] [Full Text]

				J. W. M. Martens, J. P. de Winter, M. A. Timmerman, A. McLuskey, R. H. N. van Schaik, A. P. N. Themmen, and F. H. de Jong Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells Endocrinology, July 1, 1997; 138(7): 2928 - 2936. [Abstract] [Full Text] [PDF]

				R. Borroni, Z. Liu, E. R. Simpson, and M. M. Hinshelwood A Putative Binding Site for Sp1 Is Involved in Transcriptional Regulation of CYP17 Gene Expression in Bovine Ovary Endocrinology, May 1, 1997; 138(5): 2011 - 2020. [Abstract] [Full Text] [PDF]

				R. J. Zachow, S. R. Weitsman, and D. A. Magoffin Hepatocyte Growth Factor Regulates Ovarian Theca-Interstitial Cell Differentiation and Androgen Production Endocrinology, February 1, 1997; 138(2): 691 - 697. [Abstract] [Full Text] [PDF]